The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Bold-100-001: A randomized phase 2 study of bold-100 plus FOLFOX vs FOLFOX in patients with refractory metastatic colorectal cancer.
 
Grainne O'Kane
Honoraria - AstraZeneca; Incyte; MSD Oncology; Roche; Servier/Pfizer; Zymeworks
Consulting or Advisory Role - AstraZeneca Canada; Incyte; Roche; Servier
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - MSD; Novartis; Takeda
 
Jennifer Spratlin
Research Funding - Bold Therapeutics
 
Malcolm Snow
Employment - Bold Therapeutics
Stock and Other Ownership Interests - Bold Therapeutics
 
Michelle Jones
Employment - Bold Therapeutics
Stock and Other Ownership Interests - Bold Therapeutics
 
Jim Pankovich
Employment - Bold Therapeutics
Leadership - Bold Therapeutics
Stock and Other Ownership Interests - Bold Therapeutics
Patents, Royalties, Other Intellectual Property - Bold Therapeutics